Hyperphosphatemia among end-stage renal disease patients in developing countries: A forgotten issue?

Hemodialysis International

Volumn 9, Issue 4, 2005, Pages 409-415

  Afifi, Adel ^a   El Sayed, Hesham ^a   El Setouhi, Maged ^a   Ahmed, Hayam ^a   Khalifa, Noha ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Calcium phosphorus product; Chronic kidney disease; Hemodialysis; Hyperphosphatemia; Secondary hyperparathyroidism

Indexed keywords

ALUMINUM; CALCITRIOL; CALCIUM; CALCIUM SALT; LANTHANUM CARBONATE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER;

ADULT; AGE; ARTICLE; ARTIFICIAL KIDNEY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLEARANCE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEVELOPING COUNTRY; DIALYSATE; DIALYSIS MEMBRANE; DIET; EATING HABIT; ECONOMIC ASPECT; EGYPT; ETHNOLOGY; FEMALE; GENDER; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE METABOLISM; PREVALENCE;

DEVELOPING COUNTRIES; EGYPT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PHOSPHORUS METABOLISM DISORDERS; RENAL DIALYSIS;

EID: 27744474055     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2005.01160.x     Document Type: Article

References (29)

1. Ritz E, Gross ML. Hyperphosphatemia in renal failure. Blood Purif. 2005; 23:6-9.
2. Afifi A, Karim MA. Renal replacement therapy in Egypt: First annual report of the Egyptian Society of Nephrology 1996, WHO. Eastern Mediterranean Health J. 1999;5.
3. U.S. renal data system, 2004 annual data report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, http://www.usrds.org/atlas.htm
4. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(suppl 3):S112-S119.
5. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elash-off RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342:1478-1483.
6. Blacher J, Safar ME, Guerin AP. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int. 2003; 63:1852-1860.
7. Depner TA. Daily hemodialysis efficiency: An analysis of solute kinetics. Adv Renal Replace Therapy. 2001; 5: 227-235.
8. Goodman WG. Recent developments in the management of secondary hyperparathyroidism. Kidney Int. 2001; 59:1187-1201.
9. Rufino M, de Bonis E, Martin M, Rebollo S, Martin B, Miquel R, Cobo M, Hernandez D, Torres A, Lorenzo V. Is it possible to control hyperphosphatemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant. 1998; 13(suppl 3):65-67.
10. Rocco MV, Easter L, Makoff R. Management of hyper-phosphatemia with calcium based binders. Semin Dial. 1999; 12:195-201.
11. Winchester JF, Rotellar C, Goggins M, Robino D, Rakowski TA, Argy WP. Calcium and phosphate balance in dialysis patients. Kidney Int. 1993; 43:174-178.
12. Lim VS, Flanigan MJ, Fangman J. Effect of hematocrit on solute removal during high efficiency hemodialysis. Kidney Int. 1990; 37:1557-1562.
13. Eknoyan G, Levin A, Levin N. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(suppl): 14-15.
14. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: What are the implications? Am J Kidney Dis. 2004; 43:712-720.
15. Oprisiu R, Bolosiu H, Boca I, Theodoru C, Elefterescu R, Brazier M, el Esper I, Leflon P Ledeme C, Fournier A, Heinze V. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism. Ann Med Int (Paris). 1998; 149:67-75.
16. Afifi A. Seventh annual report of the Egyptian Society of nephrology, 2003 data. Presented at the XXIV Congress of the Egyptian Society of Nephrology 15-18 February, 2005, Alexandria, Egypt.
17. Llach F. Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences. Kidney Int. 1999; 56(suppl 73):S31-S33.
18. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis. 2000; 35:1226-1237.
19. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005; 67:1179-1187.
20. Moe SM. Calcium and phosphorus regulation: Gut, parathyroid glands, and kidney. American Society of Nephrology Annual Board Review Course, September, 2000, http://www.hdcn.com/symp/00asnb/Moe/moe2.htm
21. Feinfeld DA, Sherwood LM. Parathyroid hormone and 1,25 (OH)2 D3 in chronic renal failure. Kidney Int. 1988; 33:1049-1058.
22. Kopple J. Renal disorders and nutrition. In: Shils ME, Olson JA, Shike M, Catherine RA. eds. Modern Nutrition in Heath and Disease. 9th ed. New York: Publisher Cornell University; 1998.
23. Kates DM, Andress DL. Control of hyperphosphatemia in renal failure: Role of aluminum. Semin Dial. 1996; 9:310-315.
24. Patterson LA, Deblieux PC. Hyperphosphatemia. Am J Kidney Dis. 2001; 26:30-35.
25. Lacour B, Lucas A, Auchere D, Ruellan N, de Serre Patey NM, Drueke TB. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int. 2005; 67:1062-1069.
26. Hou Sh, Zhao J, Ellman CE Hu J, Griffin Z, Spiegel DM, Bourdeau JE. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis. 1991; 18:217-224.
27. Daugirdas JT, Van Stone JC. Handbook of Dialysis. Physiologic Principles and Urea Kinetic Modeling. New York/Baltimore: Lippincott/Willams & Wilkins; 2001: p. 21.
28. Goodman WG. Importance of hyperphosphatemia in the cardio-renal axis. Nephrol Dial Transplant. 2004; 19(suppl 1): 14-18.
29. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41:1286-1291.